CIII allows people who have tried at least two oral antidepressants to use the spray on its own – without the need for more ...
Researchers delivered a dose of the “love hormone” oxytocin via a nasal spray to participants and found that it decreased ...
Recently in 2024, the agency received a report involving a patient who received the nasal solution as an injection.
Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.
J&J made it into a nasal spray to get it into the brain quickly ... they're feeling somewhat better" with Spravato. Spravato's warning label cautions about the risk of sedation and dissociation ...
The nasal spray has undergone more than a decade of ... be linked to Alzheimer's risk Delays in dreaming might be an early warning sign of Alzheimer's disease. Health News // 18 hours ago Report ...
Esketamine, the active ingredient in Spravato, is a non-selective, non-competitive antagonist of the NMDA receptor, a known ...
Johnson & Johnson's Spravato nasal spray has been FDA-approved as a stand ... Downsides of Spravato: Spravato’s warning label cautions about the risk of sedation and dissociation, respiratory ...